Paul McKenzie
Vorstandsvorsitzender bei CSL LIMITED
Vermögen: 4 Mio $ am 30.04.2024
Profil
Paul McKenzie ist Chief Operating Officer bei CSL Ltd. Er ist außerdem Mitglied des Vorstands des Massachusetts Biotechnology Council. Zuvor hatte er die Position des EVP-Pharmaceutical Operations & Technology bei Biogen, Inc. und des Vice President-R&D, Ethicon Business bei Johnson & Johnson inne. Dr. McKenzie erwarb einen Bachelor-Abschluss an der University of Pennsylvania und einen Doktortitel an der Carnegie Mellon University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CSL LIMITED
0,00% | 01.09.2023 | 22 456 ( 0,00% ) | 4 Mio $ | 30.04.2024 |
Aktive Positionen von Paul McKenzie
| Unternehmen | Position | Beginn |
|---|---|---|
| CSL LIMITED | Vorstandsvorsitzender | 06.03.2023 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Direktor/Vorstandsmitglied | - |
CSL Plasma, Inc.
 CSL Plasma, Inc. Medical/Nursing ServicesHealth Services CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL. | Geschäftsführer | - |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Vorstandsvorsitzender | 06.03.2023 |
Ehemalige bekannte Positionen von Paul McKenzie
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.06.2019 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.02.2016 |
| Society for Biological Engineering | Direktor/Vorstandsmitglied | - |
| Illinois Institute of Technology | Direktor/Vorstandsmitglied | - |
Ausbildung von Paul McKenzie
| University of Pennsylvania | Undergraduate Degree |
| Carnegie Mellon University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| CSL LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Society for Biological Engineering | |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL. | Health Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
